Pegaptanib Sodium versus Pegaptanib Sodium Combined with Macular Laser Photocoagulation or Laser Alone for Diabetic Macular Edema

Table 1

Patients’ baseline characteristics. ETDRS: early treatment diabetic retinopathy study, DME: diabetic macular edema, CMT: central macular thickness, BCVA: best corrected visual acuity.

	Pegaptanib Sodium injection group	Combined treatment group	Macular Laser Photocoagulation group
Total N° of eyes	13	12	15
N° of Male patients	8	7	10
Mean age	65,8 ± 6,1 (95% CI = 62.3, 69.2)	62,4 ± 5,5 (95% CI = 59.2, 65.6)	67 ± 8.6 (95% CI = 62.6, 71.6)
Duration of diabetes	13.7 yrs (mean)	12,8 yrs (mean)	14,9 yrs (mean)
Diffuse DME	7 eyes	7 eyes	9 eyes
Cystoid DME	6 eyes	5 eyes	6 eyes
Mean CMT (μm)	509 ± 125,6 (95% CI = 438.6, 579.4)	420,3 ± 116,3 (95% CI = 352.3, 488.2)	335 ± 91,1 (95% CI = 287.4, 382.6)
Mean BCVA (LogMAR)	0,7 ± 0,4 (95% CI = 0.5, 1)	0,3 ± 0,3 (95% CI = 0.1, 0.4)	0.3 ± 0.3 (95% CI = 0.1, 0.4)